Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 87 (2) , 243-253
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3; NSC 101-2320-B-715-002 -MY3)
- China Medical University (CMU102-S-26)
- Mackay Medical College (MMC-1001B08)
This publication has 44 references indexed in Scilit:
- Involvement of Intercellular Adhesion Molecule-1 Up-Regulation in Bradykinin Promotes Cell Motility in Human Prostate CancersInternational Journal of Molecular Sciences, 2013
- Butein Inhibits Angiogenesis of Human Endothelial Progenitor Cells via the Translation Dependent Signaling PathwayEvidence-Based Complementary and Alternative Medicine, 2013
- Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c‐Src dependent signaling pathwayThe Prostate, 2012
- Bradykinin Promotes the Chemotactic Invasion of Primary Brain TumorsJournal of Neuroscience, 2011
- IL‐1β induces expression of matrix metalloproteinase‐9 and cell migration via a c‐Src‐dependent, growth factor receptor transactivation in A549 cellsBritish Journal of Pharmacology, 2010
- JNK/AP-1 pathway is involved in tumor necrosis factor-α induced expression of vascular endothelial growth factor in MCF7 cellsBiomedicine & Pharmacotherapy, 2009
- N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastomaOncogene, 2008
- PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisCellular Signalling, 2007
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Bradykinin receptorsGeneral Pharmacology: The Vascular System, 1997